MedTrace Logo

Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy

NCT04048252 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2026-02-18

No results posted yet for this study

Summary

The development of a personalized therapeutic education program dedicated to patients with metastatic prostate cancer and receiving next-generation hormone therapy would improve their knowledge of the disease, medication adherence and quality of life.

Conditions

Interventions

OTHER

Focus group creation

Patients will join with researchers for a 2 hour recorded group discussion to highlight themes identified to require educational intervention

OTHER

Workshop

Patients will attend 3-4 workshops on eg disease knowledge, medication management and side effects, adapted physical activity and nutrition

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Nadine Houede · CHU Nimes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2021-07-05
Completion
2021-07-05

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04048252 on ClinicalTrials.gov